Nicorette Invisi Extra Strength (Nicotine)

Nicotine, the active ingredient in Nicorette Invisi Extra Strength, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adult smokers reduce withdrawal symptoms and cravings during a quit attempt.

GNH USA supplies Nicorette Invisi Extra Strength as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicotine delivered via Nicorette Invisi Extra Strength is used in smoking cessation therapy.

Smoking cessation: assists adult smokers in quitting by alleviating cravings and withdrawal symptoms. Tobacco dependence: provides a controlled nicotine dose to support gradual reduction of nicotine intake. Relapse prevention: helps maintain abstinence after initial quitting by supplying steady nicotine levels.

Nicotine patches can cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation at the application site - Redness or itching where the patch is applied - Sleep disturbance or vivid dreams - Nausea or mild stomach upset - Headache - Dizziness

Serious or Rare Side Effects: - Allergic reaction with rash or swelling - Severe skin rash or blistering - Chest pain or palpitations - Hypertension or rapid heart rate - Severe dizziness leading to fainting - Mood changes or depression

When using Nicorette Invisi Extra Strength, consider the following safety measures.

Cardiovascular assessment: evaluate patients with heart disease before initiating therapy. Medical supervision: use under guidance of a healthcare professional. Non‑smokers: not indicated for individuals who do not currently smoke. Concurrent nicotine products: avoid using other nicotine replacement therapies simultaneously. Child safety: keep patches out of reach of children and pets. Store at room temperature: keep in original packaging, protect from moisture and direct heat.

Nicotine patches may interact with other substances; awareness helps prevent complications.

Major Interactions (Avoid): - Concurrent use of other nicotine replacement products (e.g., gum, lozenges) - Combination with monoamine oxidase inhibitors (MAOIs) may increase cardiovascular risk - Use with certain cardiovascular drugs (e.g., beta‑blockers) without monitoring

Moderate Interactions (Monitor Closely): - Bupropion or varenicline may enhance nicotine‑related side effects - Certain antihypertensive agents (e.g., ACE inhibitors) may require dose adjustment - Antipsychotics metabolized by CYP2D6 may have altered plasma levels